Koch Industries Inc. boosted its position in Teleflex Incorporated (NYSE:TFX) by 47,174.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 959,669 shares of the medical technology company’s stock after buying an additional 957,639 shares during the quarter. Koch Industries Inc. owned approximately 2.13% of Teleflex worth $955,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of TFX. Janus Henderson Group PLC grew its stake in Teleflex by 50,429.2% in the 2nd quarter. Janus Henderson Group PLC now owns 1,816,020 shares of the medical technology company’s stock valued at $377,296,000 after buying an additional 1,812,426 shares during the last quarter. Marshall Wace North America L.P. grew its stake in Teleflex by 137.4% in the 2nd quarter. Marshall Wace North America L.P. now owns 518,462 shares of the medical technology company’s stock valued at $107,840,000 after buying an additional 300,069 shares during the last quarter. Principal Financial Group Inc. grew its stake in Teleflex by 93.5% in the 2nd quarter. Principal Financial Group Inc. now owns 610,398 shares of the medical technology company’s stock valued at $126,816,000 after buying an additional 294,935 shares during the last quarter. FMR LLC grew its stake in Teleflex by 46.5% in the 1st quarter. FMR LLC now owns 811,764 shares of the medical technology company’s stock valued at $157,263,000 after buying an additional 257,649 shares during the last quarter. Finally, American Century Companies Inc. grew its stake in Teleflex by 22.8% in the 2nd quarter. American Century Companies Inc. now owns 839,080 shares of the medical technology company’s stock valued at $174,327,000 after buying an additional 155,863 shares during the last quarter. Institutional investors and hedge funds own 89.75% of the company’s stock.
In other news, Director Stephen K. M.D. Klasko sold 200 shares of the stock in a transaction dated Friday, September 1st. The shares were sold at an average price of $211.75, for a total value of $42,350.00. Following the transaction, the director now directly owns 8,080 shares of the company’s stock, valued at $1,710,940. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold 600 shares of company stock worth $132,408 over the last three months. Insiders own 2.39% of the company’s stock.
Teleflex Incorporated (NYSE TFX) traded down 0.17% during mid-day trading on Friday, reaching $239.62. 88,131 shares of the company’s stock traded hands. Teleflex Incorporated has a 1-year low of $136.53 and a 1-year high of $248.68. The firm has a 50 day moving average of $232.01 and a 200 day moving average of $210.71. The firm has a market cap of $10.79 billion, a PE ratio of 45.83 and a beta of 1.07.
Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.91 by $0.13. The company had revenue of $528.60 million for the quarter, compared to analyst estimates of $518.98 million. Teleflex had a net margin of 12.36% and a return on equity of 16.12%. The company’s revenue was up 11.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.89 earnings per share. Analysts forecast that Teleflex Incorporated will post $8.28 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, September 15th. Stockholders of record on Tuesday, August 15th were given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.57%. The ex-dividend date was Friday, August 11th. Teleflex’s payout ratio is presently 26.00%.
A number of research firms recently issued reports on TFX. Needham & Company LLC raised their target price on shares of Teleflex from $228.00 to $237.00 and gave the company a “buy” rating in a research note on Tuesday, September 5th. Morgan Stanley upgraded shares of Teleflex from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $220.00 to $274.00 in a research note on Wednesday, September 6th. KeyCorp reiterated a “hold” rating on shares of Teleflex in a research note on Wednesday, September 6th. Jefferies Group LLC reiterated a “buy” rating and issued a $253.00 target price (up from $230.00) on shares of Teleflex in a research note on Wednesday, August 9th. Finally, Barclays PLC reiterated an “overweight” rating and issued a $253.00 target price (up from $230.00) on shares of Teleflex in a research note on Tuesday, September 12th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $260.75.
TRADEMARK VIOLATION WARNING: This report was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this report can be read at https://www.dispatchtribunal.com/2017/10/13/teleflex-incorporated-tfx-shares-bought-by-koch-industries-inc.html.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.